000			02013 a2200577 4500
005			20250515222743.0
264		0	_c20100728
008			201007s 0 0 eng d
022			_a1525-1594
024	7		_a10.1111/j.1525-1594.2009.00942.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLisowska, Katarzyna A
245	0	0	_aRecombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. _h[electronic resource]
260			_bArtificial organs _cMar 2010
300			_aE77-84 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntigens, CD _xmetabolism
650	0	4	_aAntigens, Differentiation, T-Lymphocyte _xmetabolism
650	0	4	_aCD28 Antigens _xmetabolism
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCD40 Ligand _xmetabolism
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aEpoetin Alfa
650	0	4	_aErythropoietin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHematinics _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aImmunophenotyping _xmethods
650	0	4	_aKidney Failure, Chronic _xblood
650	0	4	_aKinetics
650	0	4	_aLectins, C-Type _xmetabolism
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhenotype
650	0	4	_aRecombinant Proteins
650	0	4	_aRenal Dialysis
650	0	4	_aTreatment Outcome
700	1		_aDebska-Slizien, Alicja
700	1		_aRadzka, Monika
700	1		_aWitkowski, Jacek M
700	1		_aRutkowski, Boleslaw
700	1		_aBryl, Ewa
773	0		_tArtificial organs _gvol. 34 _gno. 3 _gp. E77-84
856	4	0	_uhttps://doi.org/10.1111/j.1525-1594.2009.00942.x _zAvailable from publisher's website
999			_c19802830 _d19802830